Searchable abstracts of presentations at key conferences in endocrinology

ea0094p188 | Bone and Calcium | SFEBES2023

A clinical audit on pre-operative work up and post-operative follow up in patients undergoing surgical management for primary hyperparathyroidism in a large tertiary Centre in the United Kingdom

Wijewickrama Piyumi , Simpson Helen , Baldeweg Stephanie , Srirangalingam Umasuthan , Abdel-Aziz Tarek , Kurzawinski Tom , Chung Teng-Teng

Background: Primary hyperparathyroidism (PHPT) is a common endocrine disorder. Aim of this audit was to assess clinical, biochemical parameters, localisation modalities and outcome in patients undergoing parathyroidectomy at University College London Hospital (UCLH).Methods: We audited all patients aged 15-years or above, undergoing parathyroidectomy, from 01-02-2018 to 31-12-2021 at UCLH via retrospective data collectio...

ea0098c48 | Clinical – Surgery/Applied Pathology | NANETS2023

Predictors of low-to-high grade progression in pancreatic neuroendocrine tumors

Wang Stephanie J. , Moon Farhana , Joseph Nancy , Nakakura Eric , Khuong Le Bryan , Zhang Li , Bergsland Emily

Background: Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous, with grade (G) defined by Ki67 proliferation index (<3% G1, 3-20% G2, >20% G3) or mitotic rate. The G3 NEN subgroup is further divided into well differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NEC). Grade progression can occur over time, with low-to-high grade progression (L-to-H; G1/2 to G3) the most clinically relevant form. It is associated w...

ea0081p13 | Adrenal and Cardiovascular Endocrinology | ECE2022

ARMC5 as a possible regulator of acetylation in the adrenal cortex in partnership with SIRT1

Berthon Annabel , Faucz Fabio , Feldman Benjamin , Drougat Ludivine , espiard Stephanie , Pontes Cavalcante Isadora , Ragazzon Bruno , Bertherat Jerome , Stratakis Constantine

ARMC5 is a tumor suppressor gene responsible for 20 to 40% of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) with a function that remains unclear. Based on pathway analysis from RNAseq results obtained on zebrafish models of transient Armc5 up- and down-regulation, we identified transcriptional alterations of several members of SIRT1 (sirtuin (silent mating type information regulation 2 homolog) 1) signaling in our models and hypothesized that ARM...

ea0081p19 | Adrenal and Cardiovascular Endocrinology | ECE2022

The endocrine society practice guideline revisited: why do nowadays patients undergo screening for cushing’ syndrome, and with which outcome?

Braun Leah , Vogel Frederick , Zopp Stephanie , Marchant Seiter Thomas , Rubinstein German , Berr Christina M. , Kunzel Heike , Beuschlein Felix , Reincke Martin

Background: Cushing’s syndrome (CS) is a rare but very severe condition with high morbidity and mortality. Patients are often diagnosed late in the course of the disease, many years after onset of symptoms. New approaches like extended screening of at risk populations, alternative biomarkers and clinical scores have been developed to improve diagnostic accuracy. However, there is still a debate, whether certain patient populations should be screened for CS outside the fra...

ea0090p152 | Pituitary and Neuroendocrinology | ECE2023

Protein tyrosine phosphatase receptors N and N2 regulate gonadotropin-releasing hormone neuron function

Sokanovic Srdjan , Constantin Stephanie , Lamarca Dams Aloa , Mochimaru Yuta , Smiljanic Kosara , Bjelobaba Ivana , Maso Previde Rafael , Stojilkovic Stanko

Simultaneous knockout of the neuroendocrine marker genes Ptprn and Ptprn2, which encode the protein tyrosine phosphatase receptors N and N2, respectively, causes infertility of female mice while males are fertile. To clarify the mechanism of sex-specific roles of Ptprn and Ptprn2 in mice reproduction, we analyzed the effects of their double knockout (DKO) on the hypothalamic-pituitary-gonadal axis. In DKO females, a delay in puberty and lack...

ea0090p451 | Reproductive and Developmental Endocrinology | ECE2023

Dysfunction of Estrogen Signaling as a Novel Molecular Signature of PolyCystic Ovary Syndrome

Marie Clementine , Pierre Alice , Mayeur Anne , Giton Frank , Grynberg Michael , Cohen-Tannoudji Joelle , Guigon Celine , Chauvin Stephanie

Estradiol (E2) plays an essential role in woman fertility. E2, locally produced by granulosa cells (GCs) of ovarian antral follicles, controls follicular development and selection, and triggers the gonadotropin surge that leads to ovulation. Dysovulation arising from the arrest of antral follicle growth and maturation occurs in up to 10 % of reproductive-aged women suffering polycystic ovary syndrome (PCOS). Although the diagnostic criteria for PCOS are clearly established, th...

ea0090p465 | Reproductive and Developmental Endocrinology | ECE2023

Sexual dimorphism in the LH responses to kisspeptin and senktide administration in prepubertal mice

Maione Luigi , Naule Lydie , Yang Ling Li Chloe , Magnuson Melissa , Young Jacques , Stephanie Carroll Rona , Kaiser Ursula

Introduction: The hypothalamic-pituitary-gonadal (HPG) axis is regulated by pulsatile GnRH secretion and its action on the anterior pituitary, leading to the synthesis and secretion of LH and FSH. KNDy neurons, expressing kisspeptin, neurokinin B and dynorphin A, are the GnRH/lH pulse generator and are key regulators of puberty and fertility. The HPG axis is active during prenatal and early postnatal life in humans and rodents, but then remains quiescent until puberty in both ...

ea0090ep802 | Pituitary and Neuroendocrinology | ECE2023

Diagnostic and therapeutic challenges in cyclic Cushing’s syndrome: A systematic literature review

Nowak Elisabeth , Vogel Frederick , Albani Adriana , Braun Leah , Rubinstein German , Zopp Stephanie , Ritzel Katrin , Beuschlein Felix , Theodoropoulou Marily , Reincke Martin

Background: Cyclic Cushing’s syndrome (cCS) is a sub-entity of Cushing’s syndrome (CS) associated with diagnostic and therapeutic challenges. It describes a condition, in which phases of clear-cut biochemical hypercortisolism are followed by spontaneous troughs of normal or subnormal cortisol secretion. We conducted the first systematic literature review to identify common features of cCS.Methods: We searched MEDLINE (via PubMed) for eligible s...

ea0063gp102 | Adrenal and Neuroendocrine - Basic | ECE2019

Development of a simple experiment to distinguish ARMC5 missense mutants from rare ARMC5 polymorphisms in PBMAH patients using a quantitative western blot approach

Vaczlavik Anna , Espiard Stephanie , Ribes Christopher , North Marie-Odile , Drougat Ludivine , Ragazzon Bruno , Rizk-Rabin Marthe , Bertherat Jerome

Introduction: Germline inactivating ARMC5 (Armadillo repeat containing 5) mutations are responsible for Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH). ARMC5 presents the characteristics of a tumor suppressor gene. Mutations are observed in more than 85% of patients with a clear familial presentation and 20 to 25% of apparently sporadic cases. Genetic alterations are spread all over ARMC5 coding sequence and more than two-third of them ar...

ea0063gp199 | Adrenal and Neuroendocrine - Clinical | ECE2019

LC-MS/MS measurement for urinary aldosterone improves primary aldosteronism screening

Travers Simon , Blanchard Anne , Cornu Erica , Faucard Catherine , Baffalie Laurence , Azizi Michel , Houillier Pascal , Amar Laurence , BARON Stephanie

Objective: Primary aldosteronism (PA) is the first cause of endocrine hypertension accounting for about 6% of all cases of hypertension. According to international guidelines, PA screening is based on plasma aldosterone-to-renin concentration ratio (ARR) computation. Nevertheless, measurement of urine aldosterone excretion may be of interest since it integrates aldosterone secretion over 24 hours. However, available urine aldosterone immuno-assays have poor specificity.<p ...